SLNO Advocacy Groups Oppose Additional Trial for DCCR Price Target: $5 Source: https://praderwillinews.com/2021/04/13/fpwr-pwsa-prader-willi-syndrome-fda-request-additional-dccr-clinical-trial-soleno-therapeutics/